Novel fusion proteins comprising PP14 are disclosed. The fusion proteins
retain the immunoregulatory function of native PP14, but offer
significant advantages. Methods for using the fusion proteins, and
sequence encoding the same in the treatment of immune system diseases and
disorders are therefore also disclosed, as are methods for recombinant
production of the present fusion proteins.